Who Paid My Doc
David Gemmell
Dentist, Oral and Maxillofacial Radiology Gainesville, FL Doctor of Dentistry
NPI 1780105171 CMS profile 3403650
1395 Center Dr # D8-18, Gainesville, FL 32610
General payments
$468
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, David Gemmell of Gainesville, FL is reported in the CMS Open Payments database as having received $468 across 12 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $315 | 10 | |
| 2022 | General | $153 | 2 |
Beside peers
- David Gemmell
- Dentist, Oral and Maxillofacial Radiology median
- Middle half of Dentist, Oral and Maxillofacial Radiology
- National median
In program year 2025, general payments to David Gemmell were reported at $315. Among 46 Dentist, Oral and Maxillofacial Radiology profiles paid that year, the median was $68 and the middle half received between $47 and $273.
Show as a table
| Year | David Gemmell | Dentist, Oral and Maxillofacial Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $208 | $58–$3,620 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | — | — | $132 |
| 2022 | $153 | $2,003 | $144–$11,685 | $149 |
| 2023 | $0 | $133 | $47–$8,663 | $160 |
| 2024 | $0 | $312 | $29–$14,735 | $164 |
| 2025 | $315 | $68 | $47–$273 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
48
Drug cost
$124
Branded share of claims
37.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amoxicillin | Generic | 30 | $70 | |
| Acetaminophen-Codeine Acetaminophen With Codeine | Brand | 18 | $54 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.
Records
12 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Oral and Maxillofacial Radiology in Florida
Zubad Newaz
Dentist, Oral and Maxillofacial Radiology · Ponte Vedra Beach, FL
Almas Binnal
Dentist, Oral and Maxillofacial Radiology · Gainesville, FL
Billy Phillips
Dentist, Oral and Maxillofacial Radiology · Jacksonville, FL
Andrew Pakchoian
Dentist, Oral and Maxillofacial Radiology · Jacksonville, FL
Matthew Hansen
Dentist, Oral and Maxillofacial Radiology · Gainesville, FL
Phillip Wong
Dentist, Oral and Maxillofacial Radiology · Doral, FL
Related records
Dentist, Oral and Maxillofacial Radiology in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Oral and Maxillofacial Radiology
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.